Phibro Animal Health

Phibro Animal Health

Yahoo Finance • 7 days ago

Should Value Investors Buy Envista (NVST) Stock?

The proven Zacks Rank system focuses on earnings estimates and estimate revisions to find winning stocks. Nevertheless, we know that our readers all have their own perspectives, so we are always looking at the latest trends in value, growt... Full story

Yahoo Finance • 8 days ago

3 of Wall Street’s Favorite Stocks Walking a Fine Line

3 of Wall Street's Favorite Stocks Walking a Fine Line Wall Street is overwhelmingly bullish on the stocks in this article, with price targets suggesting significant upside potential. However, it's worth remembering that analysts rarely i... Full story

Yahoo Finance • 8 days ago

Zacks.com featured highlights DiamondRock, Vertiv, Mueller Water Products and Phibro

For Immediate Release Chicago, IL – September 17, 2026 – Stocks in this week's DiamondRock Hospitality Co. DRH, Vertiv Holdings Co. VRT, Mueller Water Products, Inc. MWA and Phibro Animal Health Corp. PAHC 4 Stocks with Strong Interest C... Full story

Yahoo Finance • 23 days ago

Should Value Investors Buy Phibro Animal Health (PAHC) Stock?

Here at Zacks, we focus on our proven ranking system, which places an emphasis on earnings estimates and estimate revisions, to find winning stocks. But we also understand that investors develop their own strategies, so we are constantly l... Full story

Yahoo Finance • 24 days ago

Branded Pharmaceuticals Stocks Q2 Teardown: Bristol-Myers Squibb (NYSE:BMY) Vs The Rest

Branded Pharmaceuticals Stocks Q2 Teardown: Bristol-Myers Squibb (NYSE:BMY) Vs The Rest The end of the earnings season is always a good time to take a step back and see who shined (and who didn't). Let's take a look at how branded pharmac... Full story

Yahoo Finance • 24 days ago

Phibro’s (PAHC) Big Acquisition Bet Just Cleared Its First Full Year

Phibro Animal Health (NASDAQ:PAHC) closed out fiscal 2026 with numbers that speak for themselves. Full-year net sales topped $1.5 billion, adjusted EBITDA climbed 39% to $255 million, and adjusted diluted earnings per share jumped 48% to $... Full story

Yahoo Finance • 25 days ago

Phibro (PAHC) Q4 2026 Earnings Call Transcript

Image source: The Motley Fool. DATE Thursday, Aug. 27, 2026 at 9:00 a.m. ET CALL PARTICIPANTS President and Chief Executive Officer - Dani Bendheim Chief Financial Officer - Glenn David Chief Operating Officer - Larry Miller Full Conf... Full story

Yahoo Finance • 29 days ago

Phibro Animal Health Q4 Earnings Call Highlights

Key Points Interested in Phibro Animal Health Corporation? Here are five stocks we like better. Record fiscal 2026 results: Phibro Animal Health reported sales of $1.518 billion, up 17%, while adjusted EBITDA rose 39% to $255 million. Gro... Full story

Yahoo Finance • 2 months ago

Phibro Animal declares $0.12 dividend

* Phibro Animal (PAHC [https://seekingalpha.com/symbol/PAHC]) declares $0.12/share quarterly dividend [https://seekingalpha.com/pr/20598416-phibro-animal-health-corporation-declares-quarterly-dividend]. * Forward yield [https://seeking... Full story

Yahoo Finance • 3 months ago

2 Healthcare Stocks for Long-Term Investors and 1 We Turn Down

2 Healthcare Stocks for Long-Term Investors and 1 We Turn Down Personal health and wellness is one of the many secular tailwinds for healthcare companies. Shareholders who bet on the industry have been rewarded lately as healthcare stocks... Full story

Yahoo Finance • 3 months ago

Is Beaten-Down Phibro Animal Health Stock a Buy Following an Insider Purchase of 10,000 Shares?

E. Thomas Corcoran, Director of Phibro Animal Health Corporation(NASDAQ:PAHC), reported the acquisition of 10,000 shares of Common Stock at a weighted average price of $31.77 per share on May 29, 2026, according to a SEC Form 4 filing. Tr... Full story

Yahoo Finance • 4 months ago

Q1 Earnings Review: Branded Pharmaceuticals Stocks Led by Eli Lilly (NYSE:LLY)

As the craze of earnings season draws to a close, here’s a look back at some of the most exciting (and some less so) results from Q1. Today, we are looking at branded pharmaceuticals stocks, starting with Eli Lilly (NYSE:LLY). Looking ahe... Full story

Yahoo Finance • 4 months ago

1 Growth Stock with All-Star Potential and 2 We Question

Growth is oxygen. But when it evaporates, the consequences can be severe - ask anyone who bought Cisco in the Dot-Com Bubble or newer investors who lived through the 2020 to 2022 COVID cycle. Luckily for you, our job at StockStory is to h... Full story

Yahoo Finance • 4 months ago

Phibro's CEO transition puts this insider sale in context

Jack Bendheim, President and CEO of Phibro Animal Health Corporation(NASDAQ:PAHC), disclosed the indirect sale of 18,608 shares of Common Stock across multiple open-market transactions from May 5, 2026 through May 7, 2026, as reported in t... Full story

Yahoo Finance • 4 months ago

Phibro Animal Health (PAHC): Buy, Sell, or Hold Post Q1 Earnings?

Over the past six months, Phibro Animal Health’s shares (currently trading at $36.72) have posted a disappointing 18.5% loss, well below the S&P 500’s 11.5% gain. This may have investors wondering how to approach the situation. Is now the... Full story

Yahoo Finance • 5 months ago

Phibro Animal Health's (PAHC) CEO Sold 21,120 Shares for $1.2 Million

Jack Bendheim, President and CEO of Phibro Animal Health Corporation(NASDAQ:PAHC), reported the indirect sale of 21,120 shares of Common Stock through BFI Co. LLC over multiple transactions on April 21, 2026, April 22, 2026, and April 23,... Full story

Yahoo Finance • 5 months ago

Citi Just Made Zoetis Its Top Pick With a Buy Rating: Is the Pet Economy Boom the Best Trade of 2026?

Quick Read Zoetis (ZTS) received a Buy rating and $145 price target from Citi as top pick in animal health, citing the humanization of pets driving pain management spending in a market where 40% of dogs and cats suffer from osteoarthritis... Full story

Yahoo Finance • 6 months ago

Mid-cap healthcare stocks with A grade EPS revisions ahead of earnings

[Heart Health Concept] Eoneren/E+ via Getty Images As Q1 2026 earnings season approaches, the healthcare sector enters reporting season as one of the market's primary laggards, with the Health Care Select Sector SPDR Fund (XLV [https://se... Full story

Yahoo Finance • 6 months ago

2 Growth Stocks Set to Flourishand 1 We Question

Growth is a hallmark of all great companies, but the laws of gravity eventually take hold. Those who rode the COVID boom and ensuing tech selloff in 2022 will surely remember that the market’s punishment can be swift and severe when trajec... Full story

Yahoo Finance • 6 months ago

1 Healthcare Stock to Consider Right Now and 2 We Turn Down

Personal health and wellness is one of the many secular tailwinds for healthcare companies. Those leading the charge have not only realized strong financial performance but also propelled the broader industry’s returns as healthcare stocks... Full story